$15.95
-0.05-0.31%
At close: -
$15.99
0.040.25%
After Hours: Jan 31, 6:18 PM EDT
Comments
Loading...
Maze Therapeutics (NASDAQ:MAZE) Stock, Earnings Estimates, EPS, And Revenue
Maze Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$167.50M
Analyze the earnings history of Maze Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Maze Therapeutics (MAZE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Maze Therapeutics (MAZE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Maze Therapeutics (NASDAQ:MAZE) reporting earnings?
There are no earnings for Maze Therapeutics
What were the latest earnings per share (EPS) for Maze Therapeutics (NASDAQ:MAZE)?
There are no earnings for Maze Therapeutics
What were Maze Therapeutics’s (NASDAQ:MAZE) revenues?
There are no earnings for Maze Therapeutics
Browse earnings estimates, EPS, and revenue on all stocks.